FORUM AGENDA
Monday 24th Nov 2008
09.30 - 12.30 - Artemisia production- research into aspects of varietal developments, growing techniques and novel methods of artemisinin production
Session Introduction - Malcolm Cutler
Facilitator - Antony Ellman: Artemisinin Production Guide
Xavier Simonnet - Mediplant, Switzerland
Dr Zhong Guo-yue - President, Chongqing Institute of Chinese Medicine
Dr Xiaojun Ma - Director, Guangxi Botanical Garden for Medical Plants
Dr Pham Gia Dien, Director of Technology Center for Pharmaceutical Chemistry and Biochemistry, Vietnamese National Center for Science and Technology
David Clayton - CNAP, York, UK
Charles Giblain - BIONEXX, Madagascar
Colin Hill - Botanical Developments Ltd, UK
Christian Desmarchelier - Fundacion Mundo Sano, Argentina
12.30 - 13.00 - Semi-synthetic artemsinin
Dr Tue Nguyen - OneWorld Health, USA
13.00- 14.30 - Lunch - sponsored by MMV
14.30 - 17.30 - Artemisinin extraction, purification, derivatisation and analysis - research into improved technology aimed at reducing costs, improving efficiency, safety and environmental risk factors
Facilitator - Malcolm Cutler - FSC/MMV
Dr Ge Fahuan - Vice Director, National Engineering Research Centre for Modernisation of Extraction & Separation of TCM and Dr Tian Nan-hui, Beijing Jin Ke Group, China
Duong Ngoc Van - Saokim Pharma, Vietnam
Tong Duy Vinh - Hungtinh Co. Vietnam
Nigel Bremner - Botanical Extracts EPZ, Kenya
Christian Desmarchelier - Fundacion Mundo Sano, Argentina
Dr Bhupinder Khambay - (HFC) Kamtech Technologies / Rothamsted Research, UK
Dr Neil Sullivan - (Ionic Liquids) Bioniqs Ltd, UK and (Analysis) Sensapharm Ltd
Dr Yi Ge - (Polymers) Cranfield University, UK
Colin Hill - (Derivatisation)
Tuesday 25th Nov 2008
08:00 - 09:00 - Registration
09.00 - 09.10 - Opening remarks and Objectives
Malcolm Cutler, Andrea Bosman (WHO), Ian Bathurst (MMV)
09.10 - 09.20 - Welcome and official opening - Ms. Han Jixiu - Deputy Director of International Cooperation, The Ministry of Public Health China
09:20 - 10:00 - Keynote address: "Discovery, development and modern use of artemisinin derivatives for the treatment of malaria", "Overview of current applications of artemisinin derivatives for malaria control"
Dr Ye Zuguang, Chinese Academy of Chinese Medical Sciences, Beijing
Prof. TANG Linhua, Director, National Institute of Parasitic Diseases, Shanghai
10.00 - 10.10 - Conference format, introductions, housekeeping - Malcolm Cutler
10.10 - 10.30 - Tea/coffee break
Facilitator: Malcolm Cutler - FSC/MMV
10.30 - 12.00 - Panel presentations/discussions on Artemisia & artemisinin production experience in China, Vietnam, E. Africa, Madagascar and S.America
Charles Lu - Holley Cotec
Changbai Chen - Chongqing Heng-Star, China
Marc Blanchard, Aremisinin & Farming International
Patrick Henfrey - CEO, Botanical Extracts EPZ, Kenya
Charles Giblain - BIONEXX, Madagascar
Christian Desmarchelier - Fundacion Mundo Sano, Argentina
Colin Hill - Botanical Developments UK
12.00 - 13.00 - Panel presentations/discussions on ACT manufacturers experiences, present needs and future predictions concerning ACT trends, quality and other raw material requirements.
Bjoern Treptow - Novartis Pharma AG, Switzerland
Pradeep Nambia - IPCA, India
ICPA Mission Malaria
Yu Zhemin - Guilin Pharma, China
Emmanuel Katongole - Quality Chemicals, Uganda
Huang Qingyun - Kunming Pharmaceutical Corp
13.00 - 14.00 - Lunch sponsored by IPCA
Facilitator - Anna Wang - MMV
14.00 - 15.00 - Panel presentation/discussion on funds and market dynamics for ACT in the public sector
Ms Thuy Huong Ha - Global Fund
Andrea Bosman - WHO
Lorenzo Witherspoon - UNITAID
Presentations on behalf of UNICEF, USPMI, MSF and World Bank by A. Bosman
15:00 -16.00 - The development of the Affordable Medicines Facility for malaria (AMFm)
Ms Thuy Huong Ha - Global Fund/AMFm
16.00 - 16.20 - Tea/coffee break
16.20- 17.15 - Private sector access initiatives
Anna Wang - MMV
Inder Singh - CHAI
Presentation on behalf of PSI by A. Bosman
17.15 - 18.00 - Panel on ACT/artemisinin market forecasting
Inder Singh - CHAI, Public sector forecast
Presentation of private sector forecast for AMFm on behalf of MIT-Z by A. Bosman
Jacques Pilloy - Artepal - Artemisia/artemisinin needs
Conference Banquet sponsored by Fosun/Guilin Pharma
Wednesday 26th Nov 2008
Facilitator - Ian Bathurst - MMV
8.30 - 9.15 - Artemisinin production and pricing estimates
Jacques Pilloy - Artepal
Malcolm Cutler - MMV
9.15 - 10.00 - Potential mechanisms to secure artemisinin supply
Henk den Besten - IDA Solutions
Inder Singh - CHAI
Jacques Pilloy - Artepal
Malcolm Cutler - FSC/MMV
10.00 - 10.30 - Tea/Coffee break
10.30 - 11.00 - Report of the outcome of the 2008 Artemisinin Enterprise Conference, New technologies for artemisinin production and alternatives to artemisinin.
David Clayton - CNAP, University of York, representative of the Artemisinin Enterprise
11.00 - 11.30 - Synthetic therapies for the treatment of malaria
Jörg Möhrle - MMV
11.30 - 12.00 - Reporting of observations and recommendations from technical meetings:
1) Artemisia production
2) Artemisinin extraction, derivatisation and analysis
Presentations by facilitators of the technical meetings:
Antony Ellman
Malcolm Cutler
12.00 - 12.30 - Expansion / company presentation
12:30 - 14.00 - Lunch - sponsored by Holley - Cotec
Facilitator - Andrea Bosman - WHO
14.00 - 15.00 - Quality requirements for artemisinin production facilities. GMP for API and ACT manufacture
Maryam Mehmandoust - WHO
Valérie Faillot-Proux - Sanofi Aventis
15.00 - 16.00 - Pharmaceutical standards for artemisinin and its derivatives. Requirements for pre-qualification of ACTs
Maryam Mehmandoust - WHO
Jacque Pilloy - Artepal
Andrew Bosman - Quality Assurance of Anti-Malarial Medicines
16.00 - 16.30 - Tea/coffee break
Facilitator - Ian Boulton
16:30 -17.30 - Visions for the future
Presentation of key findings/message for sustainable development of artemisinin supply
Facilitators of the main sessions:
Malcolm Cutler
Anthony Ellman
Anna Wang
Ian Bathurst
Andrea Bosman
17.30 - Closure of the meeting